ASH Preview: Three Areas To Watch In Hematology-Oncology

 
• By Alaric DeArment

Novartis hopes a CAR-T with rapid manufacturing will be a winner, while novel bispecific antibodies in lymphoma and myeloma will make appearances, along with next-generation PI3K and BTK inhibitors.

3-D Rendering Red Blood Cells
ASH 2021 includes a variety of updates in blood cancer studies • Source: Shutterstock

More from Anticancer

More from Therapy Areas